Sign In
Buy IQV
$182.05
+1.41 (+0.781%)
At Close: Jun 03, 2026
IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates
09:10am, Tuesday, 06'th May 2025
IQVIA Holdings (IQV) came out with quarterly earnings of $2.70 per share, beating the Zacks Consensus Estimate of $2.63 per share. This compares to earnings of $2.54 per share a year ago.
IQVIA Reports First-Quarter 2025 Results
07:00am, Tuesday, 06'th May 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to
Life Science Analytics Market worth $68.81 billion by 2030 11.4% CAGR | MarketsandMarkets™
10:30am, Friday, 02'nd May 2025
DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Life Science Analytics Market , valued at US$35.69 billion in 2024, is forecasted to grow at a robust CAGR of 11.4%, reaching US$40.03 billio
Landmark Science Makes RWE Services for Biopharma Industry a Boutique Experience
10:04am, Friday, 02'nd May 2025
LOS ANGELES, May 2, 2025 /PRNewswire/ -- Landmark Science, a premier provider of real-world evidence (RWE) solutions, is redefining industry standards with its white-glove, high-touch approach to evid
IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock?
10:35am, Thursday, 01'st May 2025
Growth across the R&DS and TAS segments is anticipated to have boosted IQV's top line in the first quarter of 2025.
IQVIA (IQV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:21am, Thursday, 01'st May 2025
Evaluate the expected performance of IQVIA (IQV) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for b
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
11:07am, Tuesday, 29'th Apr 2025
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards
09:00am, Monday, 28'th Apr 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and he
IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm
09:00am, Wednesday, 23'rd Apr 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced today that the glob
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025
04:15pm, Monday, 21'st Apr 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. The
Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report
08:00am, Tuesday, 15'th Apr 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The life sciences innovation ecosystem continued to evolve and expand in 2024 as the industry continued to adapt to a complex and dynamic range of geopol
IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last?
11:45am, Thursday, 10'th Apr 2025
IQVIA (IQV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the
Here's Why Investors Must Hold IQV Stock in Their Portfolios Now
11:55am, Wednesday, 26'th Mar 2025
The IQV stock is benefiting from partner retention, acquisition and investment in AI-led innovation.
IQVIA Gains From Diversified Client Base Despite Low Liquidity Woes
12:36pm, Friday, 07'th Mar 2025
The IQV stock benefits from its healthcare-centric IT infrastructure across the globe and a treasure trove of data distinguishing it from its competitors.
UPPER NYACK, N.Y.--(BUSINESS WIRE)--When pharmacists can't give adult vaccinations, millions of people go without them.
